Fredun Pharmaceuticals Ltd Financial Ratios
FREDUNPHARMACEUTICALSLTD · Healthcare · Current price
P/E ratio
44.5x
P/B ratio
5.4x
ROE
15.8%
ROCE
19.0%
Debt / Equity
0.80
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 44.5x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 5.4x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 15.8% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 19.0% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.80 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Fredun Pharmaceuticals Ltd's latest numbers.
Fredun Pharmaceuticals Ltd profitability
Fredun Pharmaceuticals Ltd generates a return on equity of 15.8% and a return on capital employed of 19.0%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.80 and a P/E of 44.5x, Fredun Pharmaceuticals Ltd is moderately leveraged. Our overall business-quality score for the company is 3.9 / 10.
Understand the ratios
More on Fredun Pharmaceuticals Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.